Grai Orthopedic Implants
Grai Orthopedic Implants
Explore our high-performance precision instruments, implant systems, and medical solutions engineered to comply with strict global safety protocols.
A comprehensive overview of our production scale, structural quality systems, and global regulatory compliance frameworks.
As a premier China wholesale surgical sutures factory and global medical device supplier, our facility covers an expansive area of 15,000 m². To guarantee patient safety and ensure consistent clinical performance, our entire manufacturing cycle is verified to comply with international regulatory benchmarks, including certifications under ISO 13485, and BSCI. Our product range holds compliance marks for regional markets worldwide, showcasing active certifications for CE, MDR (European Medical Device Regulation), and FDA clearances.
Our operations rely on a workforce of over 500 specialized personnel, including 8 senior biomedical engineers and a dedicated team of 10 Quality Control (QC) officers. We run strict quality control processes that govern every step of our cleanroom operations. From raw material traceability to detailed inspection protocols for semi-finished and finished products, we ensure zero-defect wound closure materials reach healthcare facilities.
Technical whitepaper analyzing the mechanical profiles, chemical structures, and degradation behaviors of modern wound closure polymers.
Modern wound closure demands a deep understanding of tissue healing dynamics. Sutures must provide reliable approximation while minimizing inflammatory responses. Surgical sutures are generally divided into two main categories: absorbable and non-absorbable materials, both available in monofilament or braided (multifilament) structures.
For international medical distributors, hospital chains, and surgical device procurers, acquiring high-quality wound closure products requires balancing technical performance with supply chain reliability. Modern procurement goes beyond simple unit cost; it centers on raw material origin, batch consistency, and regulatory readiness under frameworks like the EU MDR.
Our factory addresses these requirements by maintaining strict raw material traceability and running an advanced laboratory facility for comprehensive testing. We provide reliable sourcing through:
Ensuring high performance in medical implants requires strict controls throughout the manufacturing process. Our manufacturing processes utilize micro-precision machining and wire-electrode cutting to produce suture needles with minimal tissue displacement profiles.
During production, semi-finished and finished products undergo rigorous quality control inspections. Our quality control teams verify key performance metrics, such as needle-thread attachment strength, needle bending resistance, and thread tensile strength, ensuring they meet or exceed international pharmacopeia standards (USP/EP).
A visual insight into our ISO-certified production zones, CNC machining areas, and sterile packaging labs.
High-precision tooling designed to match custom specifications for needle configurations.
Analyzing global product innovations and technical support frameworks that guarantee supplier-buyer alignment.
The wound closure industry is shifting toward bio-active and functional sutures designed to improve clinical outcomes. As an R&D-driven manufacturer, we are aligning our research with these trends:
To support our global distributors, we offer a comprehensive after-sales policy. This includes free replacement within one year for any structural manufacturing issues. In addition, we assist local agents with compliance preparation, supply chain documentation, and product training to help them navigate local hospital tender demands.
Expert answers addressing regulatory compliance, technical parameters, and procurement processes for medical devices.
Our cleanrooms operate under ISO 13485 standards. Our product certifications are regularly updated and audited by notified bodies to meet CE MDR requirements. This process includes complete raw material traceability, biological evaluation reports (ISO 10993), and clinical evaluation assessments.
We provide customization for needle-thread attachment ratios, specific suture thread lengths, color coding, and private-label sterile packaging. All custom runs undergo semi-finished and finished product inspections to verify tensile strength and sterility before release.
Our PGA sutures retain approximately 75% of their initial tensile strength at 14 days post-implantation, and 50% at 21 days. For long-term tissue support, our PDO monofilament sutures maintain approximately 75% of their tensile strength at 4 weeks, with complete absorption occurring over 180 to 210 days.
We offer a one-year free replacement policy for any products showing verified manufacturing defects. We also provide documentation and regulatory support to assist our agents in registering products with local health ministries and participating in public tenders.
Explore our complete medical catalog, including orthopedic hardware, surgical power drills, and specialized support systems.
